In vitro evaluation of magnetic resonance imaging contrast agents for labeling human liver cells: implications for clinical translation

Mol Imaging Biol. 2011 Aug;13(4):613-22. doi: 10.1007/s11307-010-0405-y. Epub 2010 Aug 25.

Abstract

Purpose: Magnetic resonance imaging (MRI) is a promising approach for non-invasive monitoring after liver cell transplantation. We compared in vitro labeling of human liver cells with nano-sized (SPIO) and micron-sized iron oxide particles (MPIO).

Procedures: The cellular iron load was quantified and phantom studies were performed using 3.0-T MRI. Transferrin receptor and ferritin gene expression, reactive oxygen species (ROS) formation, transaminase leakage, and urea synthesis were investigated over 6 days.

Results: Incubation with MPIO produced stronger signal extinctions in MRI at similar iron loads within shorter labeling time. MPIO had no negative effects on the cellular iron homeostasis or cell performance, whereas SPIO caused temporary ROS formation and non-physiologic activation of the iron metabolic pathway.

Conclusions: Our findings suggest that MPIO are suited for clinical translation of strategies for cellular imaging with MRI. Attention should be paid to iron release and oxidative stress caused by biodegradable contrast agents.

Publication types

  • Evaluation Study

MeSH terms

  • Contrast Media / metabolism*
  • Ferritins / genetics
  • Ferritins / metabolism
  • Ferrosoferric Oxide / metabolism
  • Gene Expression Regulation
  • Hepatocytes / cytology
  • Hepatocytes / metabolism*
  • Humans
  • Iron / metabolism
  • Liver / cytology*
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Reactive Oxygen Species / metabolism
  • Receptors, Transferrin / metabolism
  • Staining and Labeling*
  • Translational Research, Biomedical*

Substances

  • Contrast Media
  • Reactive Oxygen Species
  • Receptors, Transferrin
  • Ferritins
  • Iron
  • Ferrosoferric Oxide